Display Settings:

Format

Send to:

Choose Destination

    Curr Rheumatol Rep. 2008 Jul;10(3):228-34.

    Treating difficult crystal pyrophosphate dihydrate deposition disease.

    Announ N, Guerne PA.

    Hôpital Universitaire de Genève, Division de Rhumatologie, 26 Avenue de Beau-Séjour, 1211 Genève 14, Suisse.

    Calcium pyrophosphate dihydrate deposition disease is a common and potentially severe metabolic arthropathy. Early disease (in patients </= 60 years old) requires a search for one of the associated metabolic conditions, particularly hemochromatosis. Treatment is primarily symptomatic (no drug is known to prevent the progression of articular destruction). Nonsteroidal anti-inflammatory drugs and intra-articular or systemic glucocorticoids (in small amounts if use is prolonged) are the most useful treatments. Colchicine can be effective to treat recurring pseudogout, and magnesium can be effective on a preventive basis. Methotrexate showed interesting effectiveness in a small, uncontrolled series, and it can be used in the event of failure of the other treatments.

    PMID: 18638432 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information